After taking a shot at becoming a neuroscience biotech, buzzy Bay Area AI outfit Verge Genomics is dropping its only clinical ...
LA JOLLA, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Singlera Genomics, a company focused on the development and application ...
Singlera Genomics, a company focused on the application of novel DNA methylation technologies to genetic diagnosis, with ...
Wobble Genomics, a biotechnology company focused on improving cancer outcomes through better diagnosis and therapy selection, will present new data at the 2025 San Antonio Breast Cancer Symposium ...
A dire wolf de-extinction debate, CRISPR-GPT for gene editing, and more topped the list of our most popular stories in ...
Vossman discusses the genomics landscape, as well as next-generation sequencing (or NGS), and the Model Project, a ...
What Happened? Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 4.8% in the morning session after Canaccord Genuity ...
Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures.
Learn everything you need to know about Global X Genomics & Biotechnology ETF (GNOM) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see if ...
Helio Genomics and LiverRight have entered into a partnership designed to improve access to early liver cancer detection in the US.
Genomics drives climate resilience by revealing microbial impacts on Portuguese crops and supporting Amazonian pirarucu ...